EffRx Pharmaceuticals

EffRx Pharmaceuticals, a commercial-stage pharmaceutical company, focuses on late-stage development and commercialization of prescription medications for orphan indications. The business model provides superior clinical and commercial value propositions for physicians, payers and patients. EffRx pro-actively seeks European in-licensing opportunities in niche therapeutic areas, with a primary interest for rare diseases.

Switzerland effrx
Switzerland Switzerland
Switzerland effrx
Switzerland Switzerland

Alliance Members

background
CTS cts
background
EffRx Pharmaceuticals effrx
background
Medis medis
background
OrphanDC odc
background
Orpharm orpharm
background
Path Pharma path pharma
background
RareStone Group rare stone
background
Vector Pharma vector-pharma
background
Specialised Therapeutics

Territories

We offer a single entry point for our partners with orphan portfolios in ANZSEA, CEE, LATAM, MENAT, China, Cyprus, Greece, Israel, Malta, Russia and CIS, and Switzerland.

Together we can achieve more.

With deep understanding of local healthcare systems, we can support our partners to expand their business throughout the complex WODA regions.

Contact us